🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of Motor Relearning Program on Functional Mobility in Stroke Rehabilitation.

RecruitingNAAges 45 Years - 65 YearsAllUniversity of Jazan
NCT06690073 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

1. To find out the effectiveness of conventional physiotherapy on improving functional mobility of lower extremity among chronic hemiplegic subjects. 2. To find out the effcctiveness of motor relearning program along with conventional physical therapy treatment on improving functional mobility of lower extremity among chronic hemiplegic subjects. 3. To find out the effectiveness of motor relearning program along with conventional physical therapy treatment over conventional physical therapy on improving functional mobility of lower extremity among chronic hemiplegic subjects.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: The following subjects were included: * Right or left-sided chronic hemiplegic subjects. * More than six months after the onset of stroke. * Age group between 45-65 years of both genders. * Scored minimally 24/30 on the Mini-Mental State Exam (MMSE). * Motor assessment scale of sitting to standing section. * Having normal visual perception. * Able to follow verbal commands. Exclusion criteria: The following subjects were excluded: * Less than six months after the onset of stroke. * Unable to follow visual and oral commands. * The age group is below 45 years and more than 65 years. * Unilateral neglect. * Cognitive impairments (MMSE scores less than 24/30), or language deficits. * Any other neurological disorders and recent surgeries. * Previous exposure to MRP.
💊

What it tests

  • Motor Relearning Program
  • Conventional Physical Therapy
📍

Where

1 site
King Saud Medical City
Riyadh, Saudi Arabia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy